Impax implicated with Endo on FTC Antitrust violation

Discussion in 'Impax Labs/Global' started by anonymous, Apr 4, 2016 at 4:08 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Read the news??.... Impax part of scheme with Endo. Committed Antitrust violations... wonder what will happen to their cash flow?? Wonder if all their "generic" products will be investigated by FTC to see if there was anything else underhanded with any other companies..
     

  2. anonymous

    anonymous Guest

    Will that affect new hires for Rytary & ZomigNS?? Small company with not much $$ to fight Federal Govt????
     
  3. anonymous

    anonymous Guest

    read article. Endo gave Impax unfair advantage to sell a generic pain pill before going off patent. Impax had 6month exclusivity after pill went generic. Unfair trade practice under FTC Antitrust laws. Money was exchanged between Endo and Impax. Illegal. I would guess FTC will investigate ALL Impax generics now... Will be costly for company.
     
  4. anonymous

    anonymous Guest

    How is this surprising? Ask Impax about the 300mg Wellbutrin generic that was as effective as placebo. Or the Hayward violations? You don't have to dig deep to see how mismanaged this company is.
     
  5. anonymous

    anonymous Guest

    So true. Feds shutdown Hayward plant... Wall street looking heavily at Rytary success. No Medicare formulary coverage. How quickly will that drug tank with no coverage??? Zomig Nasal Spray in a generic market?? Why do you think AZ dumped that product?
     
  6. anonymous

    anonymous Guest

    ask the managed markets team. They know all about this